By Counterforce Health Team in Jaypirca (pirtobrutinib) —

Jaypirca (Pirtobrutinib) Approval with Aetna CVS Health in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Jaypirca (Pirtobrutinib) Covered by Aetna CVS Health in New York

Yes, Jaypirca (pirtobrutinib) is covered by Aetna CVS Health but requires prior authorization. The fastest path to approval: 1) Your oncologist submits a prior authorization through Aetna's provider portal with complete documentation of prior BTK inhibitor failure, 2) If denied, file an internal appeal within 60 days, 3) If still denied, request external review through New York State Department of Financial Services within 4 months. Most approvals happen within 24-48 hours when properly documented. Start today by confirming your plan requires CVS Specialty Pharmacy dispensing.

Table of Contents

Is Jaypirca Covered by Aetna CVS Health?

Jaypirca (pirtobrutinib) is included on Aetna's 2025 formulary as a non-formulary specialty medication requiring clinical evaluation. This means coverage is available but requires prior authorization for all plans.

Which Aetna Plans Cover Jaypirca:

  • Commercial employer plans
  • Individual marketplace plans
  • Medicare Advantage plans (Part D coverage)
  • Aetna Better Health Medicaid plans in New York

Key Coverage Requirements:

  • Prior authorization required (no exceptions)
  • Must be dispensed through CVS Specialty Pharmacy
  • Requires FDA-approved indication documentation
  • Step therapy requirements apply
Note: Jaypirca was added to Aetna's precertification list effective November 1, 2024, meaning all prescriptions now require approval before dispensing.

Prior Authorization Process

Who Submits the Prior Authorization?

Your oncologist or hematologist's office submits the prior authorization request. Patients cannot submit these requests directly for specialty oncology medications.

Step-by-Step Process:

  1. Clinical Documentation Gathering (1-2 days)
    • Your care team collects medical records, pathology reports, and prior treatment history
    • Required: ICD-10 codes (C83.1 for mantle cell lymphoma, C91.1 for CLL/SLL)
  2. Submission via Electronic Portal (Same day)
    • Provider submits through Aetna's provider portal
    • Alternative: Phone submission to CVS Caremark Prior Authorization at 1-800-294-5979
  3. Initial Review (24-72 hours)
  4. Decision Notification
    • Approval: Prescription can be filled at CVS Specialty
    • Denial: Written explanation provided with appeal rights

Timeline and Urgency

Standard Processing Times:

  • Initial PA Decision: 24 hours to 15 business days
  • Peer-to-Peer Review: Available upon request, usually scheduled within 2-3 business days
  • Internal Appeal: Up to 45 business days for decision
  • External Review: 30 days (standard) or 72 hours (expedited)

Expedited Reviews Available When:

  • Delay would seriously jeopardize patient health
  • Cancer progression is documented
  • Patient is hospitalized or requires immediate treatment

To Request Expedited Review: Have your physician call Aetna's clinical review line and provide medical justification for urgency.

Medical Necessity Criteria

Required Documentation for Approval:

Diagnosis Requirements:

  • Pathologically confirmed mantle cell lymphoma OR chronic lymphocytic leukemia/small lymphocytic lymphoma
  • Disease staging and current status documentation
  • Evidence of relapsed or refractory disease

Prior Treatment Documentation:

  • For MCL: At least two prior lines of systemic therapy, including a BTK inhibitor
  • For CLL/SLL: At least two prior therapies, including a BTK inhibitor AND a BCL-2 inhibitor
  • Specific drug names, treatment dates, duration, and reasons for discontinuation
  • Documentation of treatment failure, progression, or intolerance

Clinical Justification:

  • Current performance status and treatment goals
  • Contraindications to alternative therapies
  • Bleeding risk assessment and mitigation plan
  • Expected treatment duration

Bleeding Risk Mitigation Requirements:

Given Jaypirca's hemorrhagic risks, your prior authorization must address:

  • Baseline platelet count and coagulation studies
  • Current anticoagulant or antiplatelet therapy
  • Monitoring plan for CBC and bleeding symptoms
  • Risk-benefit analysis specific to your case

Understanding Your Costs

Typical Cost Structure:

  • Specialty Tier: Usually 25-40% coinsurance
  • Monthly Cost: $22,500-$26,000 without insurance
  • With Insurance: Varies by plan; often $500-$2,000+ monthly

Financial Assistance Options:

Jaypirca Savings Card (Eli Lilly):

  • Eligible patients may pay as little as $0 per month
  • Maximum annual savings: $9,200
  • Eligibility: Commercial insurance required, not eligible for government programs
  • Enroll: Call 1-833-727-4589 or visit jaypirca.lilly.com

Patient Assistance Program:

  • Available for uninsured or government-insured patients
  • Income-based eligibility
  • Contact Eli Lilly directly for applications
Important: If your plan uses "maximizer" programs, copay assistance is limited to $25/month and $350/year.

Denial Reasons and Appeals

Common Denial Reasons:

Denial Reason How to Overturn
Insufficient prior therapy documentation Submit detailed treatment history with dates, drugs, and outcomes
"Experimental/investigational" Provide FDA approval letter and NCCN guideline references
Bleeding risk concerns Submit bleeding risk assessment and monitoring protocol
Non-formulary status Request formulary exception with medical necessity letter
Quantity limits exceeded Justify dosing with FDA label and patient-specific factors

New York Appeals Process:

Level 1: Internal Appeal (Required First Step)

  • Deadline: 60 days from denial notice
  • Timeline: 45 business days for decision (72 hours if expedited)
  • How to File: Through Aetna member portal or by mail

Level 2: External Review (New York State DFS)

  • Deadline: 4 months after final internal denial
  • Timeline: 30 days standard, 72 hours expedited, 24 hours for urgent drug appeals
  • Cost: $25 fee (refunded if successful, waived for financial hardship)
  • File Online: New York DFS External Appeal Portal

Free Help Available:

  • Community Health Advocates: 888-614-5400
  • New York Consumer Assistance Program
  • Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals

Appeal Documentation Checklist:

  • ✅ Complete denial letter from Aetna
  • ✅ Medical records and pathology reports
  • ✅ Prior treatment history with outcomes
  • ✅ Physician letter of medical necessity
  • ✅ FDA label and NCCN guideline excerpts
  • ✅ Bleeding risk mitigation plan

Renewal Requirements

Jaypirca prior authorization typically requires renewal every 6-12 months. Your oncologist must document:

  • Continued Medical Necessity: Disease status and ongoing treatment need
  • Treatment Response: Imaging studies or lab values showing benefit
  • Tolerability: Assessment of side effects and dose modifications
  • Compliance: Confirmation of adherence to monitoring requirements

Renewal Timeline: Submit renewal request 30-45 days before current authorization expires to avoid treatment interruption.

CVS Specialty Pharmacy Requirements

Why CVS Specialty?

Aetna requires most specialty medications, including Jaypirca, to be dispensed through CVS Specialty Pharmacy to ensure:

  • Proper handling and storage
  • Clinical monitoring and support
  • Insurance benefit coordination

Getting Started with CVS Specialty:

  1. Prescription Transfer: Your doctor sends prescription directly to CVS Specialty
  2. Insurance Verification: CVS Specialty confirms coverage and copay
  3. Delivery Setup: Medication shipped to your home or clinic
  4. Clinical Support: Pharmacist consultation and monitoring

CVS Specialty Contact: 1-800-237-2767

Tip: CVS Specialty can often help expedite prior authorization by providing additional clinical support to your care team.

Troubleshooting Common Issues

Provider Portal Problems:

  • Portal Down: Call CVS Caremark Prior Authorization at 1-800-294-5979
  • Missing Forms: Download current forms from Aetna's provider resources
  • Submission Errors: Verify all required fields are complete, especially ICD-10 codes

Communication Issues:

  • No Response: Follow up within 5 business days of submission
  • Incomplete Information Requests: Respond within 14 days to avoid denial
  • Peer-to-Peer Requests: Accept within 24-48 hours when offered

Pharmacy Transfer Issues:

  • Prescription Stuck: Contact both current pharmacy and CVS Specialty
  • Insurance Rejection: Verify prior authorization is active and matches prescription details
  • Delivery Delays: CVS Specialty offers expedited shipping for urgent needs

Frequently Asked Questions

How long does Aetna CVS Health prior authorization take for Jaypirca in New York? Most approvals occur within 24-48 hours when properly documented. Complex cases may take up to 15 business days.

What if Jaypirca is non-formulary on my plan? Non-formulary drugs can still be covered through formulary exceptions. Your doctor must demonstrate medical necessity and why formulary alternatives are inappropriate.

Can I request an expedited appeal in New York? Yes. Both Aetna internal appeals and New York State external reviews offer expedited processing (72 hours) when delays would seriously jeopardize your health.

Does step therapy apply if I failed BTK inhibitors outside New York? Yes. Prior treatment failures from any location count toward step therapy requirements, as long as they're properly documented.

What happens if I'm hospitalized and need Jaypirca urgently? Hospitals can request emergency authorization for immediate treatment. Your outpatient prior authorization should be processed simultaneously.

How do I know if my bleeding risk is too high for approval? Your oncologist will assess bleeding risk based on platelet counts, coagulation studies, and concurrent medications. Most patients can be safely treated with appropriate monitoring.

Can I appeal to New York State if Aetna approves but limits my quantity? Yes. Quantity limit disputes can be appealed through the same process as coverage denials, especially if FDA-labeled dosing exceeds the limit.

What if I can't afford the $25 external appeal fee? New York waives the fee for financial hardship or Medicaid enrollees. Contact the Department of Financial Services to request a fee waiver.

From our advocates: "We've seen many Jaypirca denials overturned when providers include a detailed bleeding risk mitigation plan alongside prior treatment documentation. The key is showing you understand the risks and have a monitoring protocol in place. Most medical directors approve when they see thoughtful clinical planning."

Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. Our platform identifies denial reasons and drafts point-by-point rebuttals aligned to each plan's specific rules, pulling the right clinical evidence and weaving it into appeals that meet procedural requirements while tracking deadlines.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider and insurance plan for specific coverage details. Coverage policies and requirements may change. For official appeals assistance in New York, contact Community Health Advocates at 888-614-5400 or visit the New York Department of Financial Services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.